Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | PLK1 | P53350 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21389431 | 0.85 | ALDH1A1 (0.36) | ALDH1A1PLK1TSHR | |
| SCHEMBL4903302 | 0.78 | GAA (0.53) | ALDH1A1PLK1GAAPOLBHPGD | |
| SCHEMBL26146839 | 0.77 | TGM2 (0.44) | ALDH1A1GAALMNAMEN1KMT2A | |
| SCHEMBL9246872 | 0.77 | ALDH1A1 (0.43) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL489258 | 0.77 | ALDH1A1 (0.43) | ALDH1A1LMNAMEN1KMT2AMAPT | |
| SCHEMBL25141448 | 0.76 | ALDH1A1 (0.39) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL19955955 | 0.76 | ALDH1A1 (0.39) | ALDH1A1GAAMEN1KMT2AKDM4E | |
| SCHEMBL25706764 | 0.76 | ALDH1A1 (0.35) | ALDH1A1GAA | |
| SCHEMBL3146710 | 0.75 | ALDH1A1 (0.50) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| Methyl Alcohol SCHEMBL28639807 | 0.75 | ALDH1A1 (0.55) | ALDH1A1LMNAMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230151020-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) | 2023-05-18 | — | — | US | disclosed |
| EP-3512851-B1 | BETA-LACTAMASE INHIBITOR COMPOUNDS | ENTASIS THERAPEUTICS LTD (GB) | 2022-07-06 | — | — | EP | disclosed |
| WO-2020051967-A1 | PREPARATION METHOD FOR (S)-GLYCIDYL PHTHALIMIDE | 新发药业有限公司 | 2020-03-19 | — | — | WO | disclosed |
| EP-3194132-B1 | HEAT INSULATION MATERIAL BASED ON AEROGEL | UNIV DE LORRAINE (FR) | 2019-11-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230151020-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | OCIAD1, OCIAD2, EHD1 | ALDH1A1 686/4885PLK1 4246/4885GAA 2122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.